Javier P Gisbert

Summary

Publications

  1. doi request reprint Helicobacter pylori-related diseases
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Madrid, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 39:36-46. 2016
  2. doi request reprint Mentor-mentee relationship in medicine
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 40:48-57. 2017
  3. doi request reprint IV Spanish Consensus Conference on Helicobacter pylori infection treatment
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, España Electronic address
    Gastroenterol Hepatol 39:697-721. 2016
  4. doi request reprint [Helicobacter pylori-associated diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Madrid, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 38:39-48. 2015
  5. doi request reprint [Vedolizumab in the treatment of Crohn's disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 38:338-48. 2015
  6. doi request reprint Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments
    Javier P Gisbert
    Univeristy Hospital La Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Spain Electronic address
    Dig Liver Dis 47:108-13. 2015
  7. doi request reprint [Diseases linked to Helicobacter pylori infection]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 37:40-52. 2014
  8. doi request reprint Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy
    Javier P Gisbert
    Gastroenterology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Playa de Mojácar 29 Urb Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 60:458-64. 2015
  9. doi request reprint [Helicobacter pylori-related diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 36:39-50. 2013
  10. doi request reprint Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients
    Javier P Gisbert
    Gastroenterology Unit, La Princesa, Instituto de Investigación Sanitaria Princesa IP y, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    J Clin Gastroenterol 47:130-5. 2013

Collaborators

Detail Information

Publications95

  1. doi request reprint Helicobacter pylori-related diseases
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Madrid, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 39:36-46. 2016
    ..On the other hand, there is a clear disconnect between the recommendations made in consensus documents and clinical practice in primary care...
  2. doi request reprint Mentor-mentee relationship in medicine
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 40:48-57. 2017
    ..Our ultimate goal is to encourage potential mentors to become actual mentors, and potential mentees to actively seek a mentor and not lose the opportunity to receive this precious gift that many of us have been fortunate to enjoy...
  3. doi request reprint IV Spanish Consensus Conference on Helicobacter pylori infection treatment
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, España Electronic address
    Gastroenterol Hepatol 39:697-721. 2016
    ..In the present consensus, other first line alternatives and rescue treatments are also reviewed and recommended...
  4. doi request reprint [Helicobacter pylori-associated diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Madrid, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 38:39-48. 2015
    ..The incidence of H. pylori reinfection is very low in the most developed regions, but is high in developing countries...
  5. doi request reprint [Vedolizumab in the treatment of Crohn's disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 38:338-48. 2015
    ..The present article reviews the role of vedolizumab in Crohn's disease, paying special attention to its pharmacokinetic/pharmacodynamic properties, indications, effectiveness, and safety. ..
  6. doi request reprint Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments
    Javier P Gisbert
    Univeristy Hospital La Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Spain Electronic address
    Dig Liver Dis 47:108-13. 2015
    ..Aim was to evaluate the efficacy and tolerability of a moxifloxacin-containing second-line triple regimen in patients whose previous Helicobacter pylori eradication treatment failed...
  7. doi request reprint [Diseases linked to Helicobacter pylori infection]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, España Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 37:40-52. 2014
    ..The eradication of H. pylori can finally be obtained in the vast majority of patients by using a rescue strategy of up to 4 consecutive empirical therapies, without conducting bacterial cultures...
  8. doi request reprint Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy
    Javier P Gisbert
    Gastroenterology Department, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Playa de Mojácar 29 Urb Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 60:458-64. 2015
    ..Helicobacter pylori eradication is a challenge in penicillin allergy...
  9. doi request reprint [Helicobacter pylori-related diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, España Electronic address
    Gastroenterol Hepatol 36:39-50. 2013
    ..Even after the failure of 3 eradication therapies, a fourth empirical rescue therapy (with rifabutin) can be effective. ..
  10. doi request reprint Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients
    Javier P Gisbert
    Gastroenterology Unit, La Princesa, Instituto de Investigación Sanitaria Princesa IP y, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    J Clin Gastroenterol 47:130-5. 2013
    ..Second-line bismuth-containing quadruple therapy is complex and frequently induces adverse effects. A triple rescue regimen containing levofloxacin is a potential alternative; however, resistance to quinolones is rapidly increasing...
  11. doi request reprint Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice
    Adrian G McNicholl
    Digestive Services, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Gut 63:244-9. 2014
    ..The study aims to compare the effectiveness and safety of these therapies for Helicobacter pylori treatment...
  12. ncbi request reprint Third-line rescue therapy with levofloxacin after two H. pylori treatment failures
    Javier P Gisbert
    Hospital de la Princesa, Madrid, Spain
    Am J Gastroenterol 101:243-7. 2006
    ..A rescue therapy still fails in more than 20% of the cases. Our aim was to evaluate the efficacy and tolerability of a third-line levofloxacin-based regimen in patients with two consecutive Helicobacter pylori eradication failures...
  13. ncbi request reprint Thiopurine methyltransferase activity in Spain: a study of 14,545 patients
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma, Playa de Mojácar 29, Urb, Bonanza, 28669, Boadilla del Monte, Madrid, Spain
    Dig Dis Sci 52:1262-9. 2007
    ....
  14. ncbi request reprint Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure
    Javier P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Helicobacter 12:68-73. 2007
    ..Our aim was to compare two 7-day triple second-line regimens containing ranitidine bismuth citrate or levofloxacin...
  15. doi request reprint [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Espana
    Gastroenterol Hepatol 35:725.e1-38. 2012
    ..To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/)...
  16. doi request reprint Management of gastro-oesophageal reflux disease in primary care: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
    Curr Med Res Opin 25:2777-84. 2009
    ..To describe the management of gastro-oesophageal reflux disease (GERD) in primary care, as part of the RANGE (Retrospective ANalysis of GERD) study...
  17. doi request reprint Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic, histological and clinical activity, and acute-phase reactants in patients with inflammatory bowel disease
    Alicia Algaba
    Department of Gastroenterology of the Hospital Universitario de Fuenlabrada, Madrid, Spain Electronic address
    J Crohns Colitis 7:e569-79. 2013
    ....
  18. doi request reprint Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement
    Javier P Gisbert
    Hospital Universitario de la Princesa, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    Inflamm Bowel Dis 15:1485-91. 2009
    ..The aim was to evaluate the efficacy and tolerance of oral and intravenous iron treatment in anemic inflammatory bowel disease (IBD) patients, considering both hematological and quality-of-life outcomes...
  19. ncbi request reprint Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication
    Javier P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Helicobacter 10:157-71. 2005
    ..RBC with two antibiotics for 1 week...
  20. ncbi request reprint Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experience
    Yago Gonzalez-Lama
    Digestive Department, Net Center for Biomedical Research in Liver and Digestive Diseases CIBERHED, La Princesa Institute for Health Research IP, La Princesa University Hospital, Madrid, Spain
    Eur J Gastroenterol Hepatol 24:1086-91. 2012
    ..Methotrexate is useful in inflammatory bowel disease (IBD), but its role is secondary because of its limited experience and a supposedly unfavorable safety profile...
  21. doi request reprint Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study
    Ivan Guerra
    1Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain 2Department of Gastroenterology, Hospital Clinic, Barcelona, Spain 3Department of Gastroenterology, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD 4Department of Gastroenterology, Hospital Universitario La Fe, Valencia, Spain 5Department of Gastroenterology, Consorci Sanitari de Terrassa, Barcelona, Spain 6Department of Gastroenterology, Corporacio Sanitaria Parc Tauli, Sabadell, Spain 7Department of Gastroenterology, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Madrid, Spain 8Department of Gastroenterology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain 9Department of Gastroenterology, Hospital de Manises, Valencia, Spain 10Department of Gastroenterology, Hospital Clinico de Valencia, Universitat de Valencia, Valencia, Spain 11Department of Gastroenterology, Hospital de Basurto, Bilbao, Spain 12Department of Gastroenterology, Hospital del Mar, Barcelona, Spain 13Department of Gastroenterology, Hospital Universitario de Salamanca, Salamanca, Spain 14Department of Gastroenterology
    Inflamm Bowel Dis 22:894-901. 2016
    ..Psoriasis induced by anti-tumor necrosis factor-α (TNF) therapy has been described as a paradoxical side effect...
  22. doi request reprint Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Madrid, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Spain Department of Gastroenterology, Hospital Clinico Universitario, Santiago de Compostela, Spain Department of Gastroenterology, Hospital Universitari Mutua de Terrassa, Barcelona, and CIBEREHD, Spain Department of Gastroenterology, Instituto Maimonides de Investigacion Biomedica de Cordoba IMIBIC, Hospital Universitario Reina Sofia, Hospital Universitario Reina Sofia, Cordoba, Spain Department of Gastroenterology, Hospital Clinico Universitario Lozano Blesa, Zaragoza, and CIBEREHD, Spain Department of Gastroenterology, Hospital Universitario de Bellvitge IDIBELL, L Hospitalet de Llobregat, Barcelona, Spain Department of Gastroenterology, Hospital de Manises, Valencia, Spain Department of Gastroenterology, Hospital Universitario La Paz, Madrid, Spain Department of Gastroenterology, Hospital Clinico Universitario, Universitat de Valencia, Valencia, Spain Department of Gastroenterology, Hospital Clinico San Carlos and Instituto de Investigacion del Hospital Clinico San Carlos IdISSC, Madrid, Spain and Department of Gastroenterology and Hepatology, Japan
    Inflamm Bowel Dis 22:583-98. 2016
    ..There is still uncertainty about what constitutes the best therapeutic practice in ulcerative colitis (UC)...
  23. doi request reprint Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohn's disease
    Carlos Taxonera
    Gastroenterology Department, Hospital Clinico San Carlos, Madrid, Spain
    J Clin Gastroenterol 43:950-6. 2009
    ..To estimate the impact of infliximab (IFX) maintenance therapy on the use of hospital resources in patients with Crohn's disease (CD)...
  24. pmc Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Health Qual Life Outcomes 7:90. 2009
    ..This subanalysis of RANGE determined the impact of GERD on productivity in work and daily life...
  25. doi request reprint A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)
    Alicia C Marin
    Gastroenterology Unit, Hospital Universitario de La Princesa and Instituto de Investigación Sanitaria Princesa, Playa de Mojácar 29, Urb Bonanza, 28669 Boadilla del Monte, Madrid, Spain
    Expert Opin Pharmacother 14:843-61. 2013
    ..As clarithromycin is a key antibiotic in the eradication of H. pylori, the election of the rescue treatment is a matter of debate...
  26. doi request reprint Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience
    José Ignacio Fortea-Ormaechea
    Digestive Disease Department, Hospital Gregorio Maranon, Madrid, Spain
    Gastroenterol Hepatol 34:443-8. 2011
    ..To evaluate effectiveness and safety of adalimumab in CD patients of the Madrid area and identify predictors of response...
  27. doi request reprint Prospective evaluation of a clinical guideline recommending early patients discharge in bleeding peptic ulcer
    Maria Chaparro
    Gastroenterology Unit, La Princesa University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Gastroenterol Hepatol 25:1525-9. 2010
    ..To validate an early discharge policy in patients admitted with upper gastrointestinal bleeding (UGIB) due to ulcers...
  28. ncbi request reprint Effect of 5-aminosalicylates on renal function in patients with inflammatory bowel disease: 4-year follow-up study
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Gastroenterol Hepatol 31:477-84. 2008
    ..Our aim was to conduct a retrospective study of IBD patients, both with and without 5-ASA treatment, who underwent regular evaluation of renal function over a 4-year period...
  29. ncbi request reprint Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Inflamm Bowel Dis 13:1106-14. 2007
    ....
  30. ncbi request reprint Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Am J Gastroenterol 100:1935-40. 2005
    ..To study the efficacy of esomeprazole-based triple therapy in Helicobacter pylori eradication and to evaluate, by a randomized trial, the effect of increasing the dose of esomeprazole or prolonging the treatment...
  31. ncbi request reprint Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding
    Javier P Gisbert
    Department of Gastroenterology, Hospital de la Princesa, Madrid, Spain
    Helicobacter 12:279-86. 2007
    ..To evaluate the effect of Helicobacter pylori eradication on ulcer bleeding recurrence in a prospective, long-term study including more than 400 patients...
  32. doi request reprint Infliximab therapy reverses the increase of allograft inflammatory factor-1 in serum and colonic mucosa of rats with inflammatory bowel disease
    Irene D Román
    a Department of Systems Biology, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, University of Alcala, Alcala de Henares, Spain
    Biomarkers 22:133-144. 2017
    ..Our purpose was to study the molecular basis of infliximab (IFX) effect on colon mucosa in a colitis model and to identify new biomarkers of mucosal healing...
  33. doi request reprint How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study
    Fernando Bermejo
    Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain Electronic address
    Dig Liver Dis 45:733-7. 2013
    ..Tuberculosis reactivation can lead to severe complications in patients treated with anti-tumour necrosis factor-alpha...
  34. ncbi request reprint Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Hepatogastroenterology 53:399-404. 2006
    ..To prospectively evaluate whether, in patients with inflammatory bowel disease, the choice of azathioprine (AZA) or 6-mercaptopurine (6-MP) dose based on thiopurine methyltransferase (TPMT) activity prevents myelotoxicity...
  35. doi request reprint Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis
    Carlos Taxonera
    Inflammatory Bowel Disease Unit, Department of Gastroenterology, Hospital Clinico San Carlos, C Profesor Martin Lagos s n, 28040, Madrid, Spain
    Dig Dis Sci 60:3075-84. 2015
    ..The outcomes of infliximab dose escalation in ulcerative colitis (UC) have not been well evaluated...
  36. pmc Effectiveness of infliximab after adalimumab failure in Crohn's disease
    Maria Chaparro
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, 28006 Madrid, Spain
    World J Gastroenterol 18:5219-24. 2012
    ..To evaluate the effectiveness of infliximab as a second-line therapy in Crohn's disease patients after adalimumab failure...
  37. doi request reprint Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
    Scand J Gastroenterol 48:652-6. 2013
    ..Eradication with rescue regimens may be challenging after failure of key antibiotics such as clarithromycin and nitroimidazoles...
  38. doi request reprint Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines
    Carlos Teruel
    Department of Gastroenterology, Hospital Ramon y Cajal, Madrid, Spain
    Am J Gastroenterol 105:2003-8. 2010
    ..Immunomodulators are used as maintenance treatment of inflammatory bowel disease (IBD). Data regarding their possible effects in the course of pregnancy when the father is exposed at the time of conception are limited...
  39. doi request reprint Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: a European observational study
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Eur J Gen Pract 15:154-60. 2009
    ..To report on the primary care consultation rates and clinical characteristics of patients with gastro-oesophageal reflux disease (GERD) as part of the RANGE (Retrospective ANalysis of GERD) observational study...
  40. ncbi request reprint Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Am J Gastroenterol 101:2769-76. 2006
    ....
  41. ncbi request reprint Helicobacter pylori "rescue" therapy after failure of two eradication treatments
    Javier P Gisbert
    Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain
    Helicobacter 10:363-72. 2005
    ....
  42. ncbi request reprint How effective are rescue H. pylori eradication therapies in patients with dyspepsia?
    Javier P Gisbert
    Gastroenterololgy Unit, La Princesa University Hospital, Madrid, Spain
    Nat Clin Pract Gastroenterol Hepatol 2:180-1. 2005
  43. ncbi request reprint Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis
    Javier P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Am J Gastroenterol 101:848-63. 2006
    ..To perform a systematic review and a meta-analysis of diagnostic accuracy of the different tests aimed to detect Helicobacter pylori infection in patients with upper gastrointestinal bleeding (UGIB)...
  44. ncbi request reprint [Role of biological markers in inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 30:117-29. 2007
    ..Like calprotectin, fecal lactoferrin is also quantified by a simple and inexpensive ELISA method, although there is considerably less experience with this latter marker...
  45. ncbi request reprint [Common errors in the management of outpatients with inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Espana
    Gastroenterol Hepatol 30:469-86. 2007
  46. doi request reprint Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Madrid, Spain
    Inflamm Bowel Dis 15:1190-8. 2009
    ....
  47. doi request reprint Outcome after a dose "de-intensification" strategy with anti-TNF drugs in patients with Crohn's disease
    Maria Chaparro
    Gastroenterology Department, La Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain Electronic address
    Gastroenterol Hepatol 39:255-60. 2016
    ..Once patients have achieved remission, dose "de-intensification" can be used for cost and safety reasons...
  48. doi request reprint Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients
    Maria Chaparro
    Gastroenterology Unit, La Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Inflamm Bowel Dis 19:1404-10. 2013
    ..To evaluate the safety of thiopurines in patients with inflammatory bowel disease. To identify predictive factors associated with the development of thiopurine-induced adverse events...
  49. doi request reprint Sequential therapy for Helicobacter pylori eradication: a critical review
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Clin Gastroenterol 44:313-25. 2010
    ..Alternative treatment regimens for standard triple therapy are urgently needed...
  50. doi request reprint Soluble angiogenic factors in patients with acute pancreatitis
    Laura Espinosa
    Servicio de Aparato Digestivo, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    J Clin Gastroenterol 45:630-7. 2011
    ..Angiogenic factors are involved in the physiopathology of several inflammatory diseases and they probably play a role in the pathogenesis of acute pancreatitis (AP)...
  51. ncbi request reprint [Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Med Clin (Barc) 124:697-709. 2005
    ..In the meantime, as it occurs with any controversial indication, the decision of the doctor facing a patient infected by H. pylori and needing maintenance therapy with PPIs should be assessed on a case by case basis...
  52. doi request reprint Azathioprine desensitizes liver cancer cells to insulin-like growth factor 1 and causes apoptosis when it is combined with bafilomycin A1
    Borja Hernández-Breijo
    Departamento de Biología de Sistemas, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Universidad de Alcala, 28871 Alcala de Henares, Spain
    Toxicol Appl Pharmacol 272:568-78. 2013
    ..We are presenting here a novel mechanism of action of azathioprine, which could be useful in treatment of IGF-1 dependent tumors, especially in its combination with other drugs...
  53. doi request reprint Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent
    María Del Carmen R-Grau
    Department of Gastroenterology, La Princesa, Instituto de Investigación Sanitaria Princesa IIS IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain Electronic address
    Dig Liver Dis 48:613-9. 2016
    ..Anti-TNF treatment is effective for Crohn's disease (CD); however, some patients did not achieve remission with these drugs...
  54. doi request reprint [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study]
    Ignacio Marin-Jimenez
    Servicio de Gastroenterologia, Hospital Gregorio Maranon, Madrid, España Electronic address
    Gastroenterol Hepatol 37:495-502. 2014
    ....
  55. ncbi request reprint Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation
    Carlos Taxonera
    Inflammatory Bowel Disease Unit, Department of Gastroenterology, Hospital Clinico San Carlos, C Profesor Martin Lagos s n, 28040, Madrid, Spain
    Dig Dis Sci . 2016
    ..The impact of prior anti-TNF use on "real-life" outcomes of adalimumab therapy in ulcerative colitis (UC) is not well known...
  56. ncbi request reprint Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Eur J Gastroenterol Hepatol 16:89-99. 2004
    ....
  57. ncbi request reprint [Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Spain
    Med Clin (Barc) 125:301-16. 2005
  58. ncbi request reprint Potent gastric acid inhibition in Helicobacter pylori eradication
    Javier P Gisbert
    Gastroenterology Service, La Princesa University Hospital, Madrid, Spain
    Drugs 65:83-96. 2005
    ..pylori infection. However, all PPIs (omeprazole, lansoprazole, pantoprazole, rabeprazole, and esomeprazole) are equivalent when given together with two antibiotics to cure the infection...
  59. doi request reprint Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers
    Rosario López-Rodríguez
    Clinical Pharmacology Service, Instituto Teofilo Hernando, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Pharmacol Res 58:77-84. 2008
    ....
  60. doi request reprint Phenotypic concordance in familial inflammatory bowel disease (IBD). Results of a nationwide IBD Spanish database
    Eduard Cabre
    Hospital Universitari Germans Trias i Pujol, Badalona, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Madrid, Spain Electronic address
    J Crohns Colitis 8:654-61. 2014
    ..We assessed the concordance for disease type and phenotypic features in IBD families...
  61. doi request reprint Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Inflamm Bowel Dis 15:1746-54. 2009
    ..Finally, in patients with Crohn's disease who have undergone ileocolonic resection, those with higher lactoferrin fecal levels might be more prone to postsurgical recurrence...
  62. doi request reprint Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature
    Maria Chaparro
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    J Crohns Colitis 7:e61-5. 2013
    ..Surveillance for colorectal cancer should be strongly recommended in this group of patients...
  63. ncbi request reprint Utility of assessing thiopurine S-methyltransferase polymorphisms before azathioprine therapy
    Teresa Cabaleiro
    Service of Clinical Pharmacology, Hospital Universitario de la Princesa, Instituto Teofilo Hernando, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Curr Drug Metab 13:1277-93. 2012
    ..However, further research about the availability of a reliable and universal screening method and more costeffectiveness studies are necessary...
  64. doi request reprint [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Espana
    Aten Primaria 44:727.e1-727.e38. 2012
    ..To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/)...
  65. doi request reprint Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease
    Cristina López-Martín
    Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Gastroenterol Hepatol 34:385-92. 2011
    ..Thiopurine immunomodulators are the most commonly used immunosuppressants in inflammatory bowel disease...
  66. doi request reprint The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patients
    Alicia Algaba
    Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain Gastroenterology Unit, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain Gastroenterology Unit, Hospital de Sabadell, Institut Parc Taulí, Sabadell, Barcelona, Spain and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain
    Inflamm Bowel Dis 20:695-702. 2014
    ..The aim of the study was to compare the concentrations of angiogenic proteins in patients with inflammatory bowel disease (IBD) and healthy controls and to analyze changes in the levels during infliximab and adalimumab treatment...
  67. doi request reprint Corticosteroids modulate angiogenic soluble factors in ulcerative colitis patients
    Inés D Pousa
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Dig Dis Sci 56:871-9. 2011
    ....
  68. ncbi request reprint [Common errors in the management of the seriously ill patient with inflammatory bowel disease]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Gastroenterol Hepatol 30:294-314. 2007
  69. doi request reprint Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study
    Ignacio Marin-Jimenez
    Gastroenterology Unit, Hospital General Universitario Gregorio Maranon, Instituto de Investigación Sanitaria Gregorio Marañón IiSGM, Madrid, Spain
    Am J Gastroenterol 111:261-8. 2016
    ..We compared the diagnostic performance of the Simple Clinical Colitis Activity Index (SCCAI) self-administered by patients with ulcerative colitis (UC) at home (through a website) with the in-clinic gastroenterologist-assessed SCCAI...
  70. ncbi request reprint Open-label infliximab therapy in ulcerative colitis: a multicenter survey of results and predictors of response
    Yago Gonzalez-Lama
    Digestive Department of La Princesa Universitary Hospital, Madrid, Spain
    Hepatogastroenterology 55:1609-14. 2008
    ..We aimed to evaluate the efficacy and safety of infliximab in UC patients of the Madrid area, looking for clinical predictors of response...
  71. doi request reprint Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, Spain
    Am J Gastroenterol 103:1783-800. 2008
    ..Our aim was to conduct a review of AZA/MP-induced myelotoxicity in inflammatory bowel disease (IBD) patients...
  72. doi request reprint Validation of a genotyping method for analysis of TPMT polymorphisms
    Manuel Román
    Clinical Pharmacology Service, Hospital Universitario de la Princesa, Instituto Teofilo Hernando, UAM, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Clin Ther 34:878-84. 2012
    ..Several mutations in the TPMT gene correlate with low enzyme activity and adverse effects such as myelotoxicity. Hence, genotyping TPMT makes it possible to identify patients at high risk for drug toxicity...
  73. ncbi request reprint 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding
    Javier P Gisbert
    Service of Gastroenterology and Hepatology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Helicobacter 12:231-7. 2007
    ..To evaluate the accuracy of (13)C-urea breath test (UBT) to detect Helicobacter pylori infection in patients hospitalized with peptic ulcer bleeding and treated with proton pump inhibitors (PPIs)...
  74. doi request reprint Should we monitor vitamin B12 and folate levels in Crohn's disease patients?
    Fernando Bermejo
    Department of Gastroenterology, Hospital Universitario de Fuenlabrada, Madrid, Spain
    Scand J Gastroenterol 48:1272-7. 2013
    ..Our aim was to define the prevalence of vitamin B12 and folate deficiency in patients with Crohn's disease and to identify predictive factors associated with such abnormalities...
  75. ncbi request reprint Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Am J Gastroenterol 102:1518-27. 2007
    ..As long-term hepatotoxicity seems to be an unpredictable and potentially severe adverse drug reaction of 6-thioguanine, this drug should not be administered outside a clinical trial setting. (Am J Gastroenterol 2007;102:1518-527)...
  76. doi request reprint Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response
    Maria Chaparro
    Gastroenterology Unit of Hospital La Princesa, Madrid, Spain
    J Clin Gastroenterol 45:113-8. 2011
    ..The efficacy of infliximab therapy in patients with Crohn's disease (CD) is unknown beyond 12 months. For patients who lose their initial response, consideration can be given to dose "escalation" to regain therapeutic benefit...
  77. ncbi request reprint Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis
    Javier P Gisbert
    Department of Gastroenterology, La Princesa University Hospital, Universidad Autonoma, Madrid, Spain
    Am J Gastroenterol 101:1921-30. 2006
    ..To perform a systematic review and a meta-analysis of accuracy of monoclonal stool antigen test (SAT) for the diagnosis of Helicobacter pylori infection...
  78. doi request reprint [Prevalence and characteristics of anemia and iron deficiency in patients hospitalized for gastrointestinal diseases in Spain]
    Fermin Mearin
    Servicio de Aparato Digestivo, Centro Medico Teknon, Barcelona, España Electronic address
    Gastroenterol Hepatol 36:499-507. 2013
    ..To determine the prevalence and characteristics of anemia and iron deficiency in patients hospitalized for gastrointestinal diseases...
  79. ncbi request reprint Transplacental transfer of immunosuppressants and biologics used for the treatment of inflammatory bowel disease
    Maria Chaparro
    Gastroenterology Unit, Hospital Universitario de la Princesa, Diego de Leon 62, 28006, Madrid, Spain
    Curr Pharm Biotechnol 12:765-73. 2011
    ..Infliximab and adalimumab bind the FcRn-receptor as other IgG proteins do. The mechanisms of the diffusion of certolizumab across the placenta barrier remain unknown...
  80. ncbi request reprint Evolution of Helicobacter pylori therapy from a meta-analytical perspective
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Universidad Autonoma, Madrid, Spain
    Helicobacter 12:50-8. 2007
    ..PPI-based triple therapy with amoxicillin and levofloxacin is at least equally effective and better tolerated...
  81. pmc "Rescue" regimens after Helicobacter pylori treatment failure
    Javier P Gisbert
    Gastroenterology Unit, Hospital de la Princesa, Madrid, Spain
    World J Gastroenterol 14:5385-402. 2008
    ..Therefore, the attitude in H pylori eradication therapy failure, even after two or more unsuccessful attempts, should be to fight and not to surrender...
  82. doi request reprint [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Espana
    Gastroenterol Hepatol 34:15-26. 2011
    ..Even after three previous H. pylori eradication failures, an empirical fourth-line rescue treatment with rifabutin may be effective...
  83. doi request reprint Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Madrid, Spain
    Am J Gastroenterol 104:760-7. 2009
    ..To review the frequency with which infliximabloses its effect and dose "intensification" is required for Crohn's disease treatment...
  84. doi request reprint Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Am J Gastroenterol 108:1426-38. 2013
    ..However, data regarding their safety during pregnancy and breastfeeding are scarce. The aim of this study was to critically review available data on the safety of anti-TNF therapy during pregnancy and breastfeeding in women with IBD...
  85. doi request reprint Evaluation of liver fibrosis by transient elastography in methotrexate treated patients
    Almudena Barbero-Villares
    Servicio de Aparato Digestivo y Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain
    Med Clin (Barc) 137:637-9. 2011
    ....
  86. doi request reprint Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease
    Javier P Gisbert
    Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain
    Inflamm Bowel Dis 19:554-8. 2013
    ....
  87. doi request reprint [Helicobacter pylori-related diseases]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Gastroenterol Hepatol 35:12-25. 2012
    ..Even after three eradication therapies have failed, an empirical rescue therapy (with rifabutin) can be effective. H. pylori reinfection is highly frequent in developing countries, probably due to intrafamilial transmission...
  88. ncbi request reprint The influence of CYP2C19 genetic polymorphism on the pharmacokinetics/- pharmacodynamics of proton pump inhibitor-containing Helicobacter pylori treatments
    Dolores Serrano
    Department of Pharmaceutical Technology, Faculty of Pharmacy, Complutense University, Madrid, Spain
    Curr Drug Metab 13:1303-12. 2012
    ..In Helicobacter pylori infection, a significantly lower eradication rate was seen in extensive metabolizers with omeprazole but no with rabeprazole...
  89. ncbi request reprint Pathophysiological bases of eosinophilic esophagitis therapy
    Ricardo Moreno-Borque
    Alergología Clínica Servicio de Medicina Interna, Hospital Rey Juan Carlos I, Mostoles, Madrid, Spain
    Inflamm Allergy Drug Targets 12:46-53. 2013
    ..Prolonged treatment is advised for EoE because it recurs frequently, particularly on discontinuation of therapy. Experimental treatments using immunotherapy are being investigated, but their safety and efficacy are yet to be defined...
  90. ncbi request reprint Influence of thymidylate synthase DNA polymorphisms and gender on the clinical evolution of patients with advanced colorectal cancer
    María Encarnación Fernández-Contreras
    Department of Gastroenterology and Hepathology, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, C Diego de Leon 62, 28006 Madrid, Spain
    Oncol Rep 23:1393-400. 2010
    ..004; interaction P=0.06). TS genotype did not affect survival among women. The present study supports that the effect of TS polymorphisms on the clinical evolution of advanced CRC patients is significantly influenced by gender...
  91. doi request reprint Response to letter: folate deficiency in Crohn's disease
    Fernando Bermejo
    Gastroenterology Units, Hospital Universitario de Fuenlabrada, Madrid, Spain
    Scand J Gastroenterol 49:255-6. 2014
    ..A significant proportion of patients with Crohn's disease suffer from folate deficiency, suggesting that regular screening should be performed...
  92. doi request reprint [Rescue therapy after Helicobacter pylori eradication failure]
    Javier P Gisbert
    Servicio de Aparato Digestivo, Hospital Universitario de la Princesa, Madrid, Espana
    Gastroenterol Hepatol 34:89-99. 2011
    ..Finally, rifabutin-based therapies have achieved promising results and are even effective in patients with multiple failures or multiple antibiotic resistance...
  93. doi request reprint Effect of Infliximab in oxidised serum albumin levels during experimental colitis
    David Cano-Martínez
    Department of Systems Biology, Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas CIBERehd, University of Alcala, Alcala de Henares, Spain
    Biomarkers 19:693-701. 2014
    ..Both decreased after IFX treatment. This suggests that oxidised albumin could be a useful biomarker for monitoring inflammatory bowel disease...
  94. doi request reprint Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease
    Javier P Gisbert
    Gastroenterology Unit, Hospital Universitario de la Princesa, Madrid, and Centro de Investigación Biomédica en Red de enfermedades hepáticas y digestivas CIBERehd, Spain
    Am J Gastroenterol 103:1299-307. 2008
    ..Anemia diagnosis and treatment must not be neglected in IBD patients, and several misconceptions should be promptly abandoned...
  95. doi request reprint Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis
    Maria Chaparro
    Department of Gastroenterology and Hepatology, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain
    Digestion 80:1-17. 2009
    ..The real accuracy of computed tomographic colonography (CTC) is still unknown...